Longeveron Llc Stock Performance
| LGVN Stock | USD 1.52 0.01 0.65% |
The company secures a Beta (Market Risk) of 0.6, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Longeveron LLC's returns are expected to increase less than the market. However, during the bear market, the loss of holding Longeveron LLC is expected to be smaller as well. At this point, Longeveron LLC has a negative expected return of -0.43%. Please make sure to verify Longeveron LLC's skewness, as well as the relationship between the day median price and relative strength index , to decide if Longeveron LLC performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Longeveron LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
| Begin Period Cash Flow | 10.5 M |
Longeveron |
Longeveron LLC Relative Risk vs. Return Landscape
If you would invest 206.00 in Longeveron LLC on December 1, 2024 and sell it today you would lose (54.00) from holding Longeveron LLC or give up 26.21% of portfolio value over 90 days. Longeveron LLC is currently does not generate positive expected returns and assumes 3.9518% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than Longeveron, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Longeveron LLC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Longeveron LLC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Longeveron LLC, and traders can use it to determine the average amount a Longeveron LLC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1086
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LGVN |
Estimated Market Risk
| 3.95 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.43 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Longeveron LLC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Longeveron LLC by adding Longeveron LLC to a well-diversified portfolio.
Longeveron LLC Fundamentals Growth
Longeveron Stock prices reflect investors' perceptions of the future prospects and financial health of Longeveron LLC, and Longeveron LLC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Longeveron Stock performance.
| Return On Equity | -1.11 | ||||
| Return On Asset | -0.53 | ||||
| Operating Margin | (6.01) % | ||||
| Current Valuation | 1.67 M | ||||
| Shares Outstanding | 13.35 M | ||||
| Price To Book | 0.89 X | ||||
| Price To Sales | 12.18 X | ||||
| Revenue | 709 K | ||||
| EBITDA | (20.06 M) | ||||
| Cash And Equivalents | 27.06 M | ||||
| Cash Per Share | 1.29 X | ||||
| Total Debt | 2.04 M | ||||
| Debt To Equity | 0.1 % | ||||
| Book Value Per Share | 1.73 X | ||||
| Cash Flow From Operations | (19 M) | ||||
| Earnings Per Share | (5.62) X | ||||
| Total Asset | 12.08 M | ||||
| Retained Earnings | (84.98 M) | ||||
About Longeveron LLC Performance
By examining Longeveron LLC's fundamental ratios, stakeholders can obtain critical insights into Longeveron LLC's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Longeveron LLC is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company was incorporated in 2014 and is based in Miami, Florida. Longeveron operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 18 people.Things to note about Longeveron LLC performance evaluation
Checking the ongoing alerts about Longeveron LLC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Longeveron LLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Longeveron LLC generated a negative expected return over the last 90 days | |
| Longeveron LLC may become a speculative penny stock | |
| Longeveron LLC has high historical volatility and very poor performance | |
| Longeveron LLC has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 709 K. Net Loss for the year was (21.41 M) with profit before overhead, payroll, taxes, and interest of 1.35 M. | |
| Longeveron LLC currently holds about 27.06 M in cash with (19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29. | |
| Longeveron LLC has a frail financial position based on the latest SEC disclosures |
- Analyzing Longeveron LLC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Longeveron LLC's stock is overvalued or undervalued compared to its peers.
- Examining Longeveron LLC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Longeveron LLC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Longeveron LLC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Longeveron LLC's stock. These opinions can provide insight into Longeveron LLC's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Longeveron LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Longeveron Stock, please use our How to Invest in Longeveron LLC guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longeveron LLC. If investors know Longeveron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longeveron LLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Longeveron LLC is measured differently than its book value, which is the value of Longeveron that is recorded on the company's balance sheet. Investors also form their own opinion of Longeveron LLC's value that differs from its market value or its book value, called intrinsic value, which is Longeveron LLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longeveron LLC's market value can be influenced by many factors that don't directly affect Longeveron LLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longeveron LLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Longeveron LLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longeveron LLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.